Pasar al contenido principal

APRENDIZAJE AUTOMATICO PARA LA MODELIZACION DE LA DINAMICA MOLECULAR DE LAS PROTEINAS GPCR

PID2019-104551RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITECNICA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Machine learning for clinical decision-making: challenges and opportunities in cardiovascular imaging

  • Sanchez-Martinez, Sergio
  • Camara, Oscar
  • Piella Fenoy, Gemma
  • Cikes, Maja
  • González Ballester, Miguel Ángel, 1973-
  • Miron, Marius
  • Vellido Alcacena, Alfredo
  • Gómez, Emilia
  • Fraser, Alan G.
  • Bijnens, Bart
The use of machine learning (ML) approaches to target clinical problems is called to revolutionize clinical decision-making in cardiology. The success of these tools is dependent on the understanding of the intrinsic processes being used during the conventional pathway by which clinicians make decisions. In a parallelism with this pathway, ML can have an impact at four levels: for data acquisition, predominantly by extracting standardized, high-quality information with the smallest possible learning curve; for feature extraction, by discharging healthcare practitioners from performing tedious measurements on raw data; for interpretation, by digesting complex, heterogeneous data in order to augment the understanding of the patient status; and for decision support, by leveraging the previous steps to predict clinical outcomes, response to treatment or to recommend a specific intervention. This paper discusses the state-of-the-art, as well as the current clinical status and challenges associated with the two later tasks of interpretation and decision support, together with the challenges related to the learning process, the auditability/traceability, the system infrastructure and the integration within clinical processes in cardiovascular imaging., This study was supported by the Spanish Ministry of Economy and Competitiveness (María de Maeztu Programme for R&D [MDM-2015-0502], Madrid, Spain) and by the Fundació La Marató de TV3 (n°20154031, Barcelona, Spain). The work of SS-M was supported by IDIBAPS and by the HUMAINT project of the Joint Research Centre of the European Commission. AV's contribution is funded by Spanish research project PID2019-104551RB-I00.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Radiomics-based assessment of optical coherence tomography angiography images for diabetic retinopathy diagnosis

  • Carrera Escale, Laura
  • Benali Bendahmane, Anass
  • Rathert, Ann Christin
  • Martín Pinardel, Ruben
  • Bernal Morales, Carolina
  • Alé Chilet, Anibal
  • Barraso Rodrigo, Marina
  • Marín Martinez, Sara
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
  • Romero Merino, Enrique|||0000-0003-2404-5716
Purpose: To evaluate the diagnostic accuracy of machine learning (ML) techniques applied to radiomic features extracted from OCT and OCT angiography (OCTA) images for diabetes mellitus (DM), diabetic retinopathy (DR), and referable DR (R-DR) diagnosis. Design: Cross-sectional analysis of a retinal image dataset from a previous prospective OCTA study (ClinicalTrials.gov NCT03422965). Participants: Patients with type 1 DM and controls included in the progenitor study. Methods: Radiomic features were extracted from fundus retinographies, OCT, and OCTA images in each study eye. Logistic regression, linear discriminant analysis, support vector classifier (SVC)-linear, SVC-radial basis function, and random forest models were created to evaluate their diagnostic accuracy for DM, DR, and R-DR diagnosis in all image types. Main Outcome Measures: Area under the receiver operating characteristic curve (AUC) mean and standard deviation for each ML model and each individual and combined image types. Results: A dataset of 726 eyes (439 individuals) were included. For DM diagnosis, the greatest AUC was observed for OCT (0.82, 0.03). For DR detection, the greatest AUC was observed for OCTA (0.77, 0.03), especially in the 3 x 3 mm superficial capillary plexus OCTA scan (0.76, 0.04). For R-DR diagnosis, the greatest AUC was observed for OCTA (0.87, 0.12) and the deep capillary plexus OCTA scan (0.86, 0.08). The addition of clinical variables (age, sex, etc.) improved most models AUC for DM, DR and R-DR diagnosis. The performance of the models was similar in unilateral and bilateral eyes image datasets. Conclusions: Radiomics extracted from OCT and OCTA images allow identification of patients with DM, DR, and R-DR using standard ML classifiers. OCT was the best test for DM diagnosis, OCTA for DR and R-DR diagnosis and the addition of clinical variables improved most models. This pioneer study demonstrates that radiomics-based ML techniques applied to OCT and OCTA images may be an option for DR screening in patients with type 1 DM., The authors made the following disclosures: A.V.: Grants e Spanish research grant (grant no.: PID2019-104551RB-I00). J.Z.V.: Grant e Fundació La Marató de TV3, La Marató 2015, Diabetis i Obesitat (grant no.: 201633.10), Instituto de Salud Carlos III (grant nos.: PI18/00518, PI21/01384). E.R.: Grant e Spanish research grant (grant no.: PID2019-104551RB-I00)., Peer Reviewed, Article signat per 20 autors/es: Laura Carrera-Escalé, MSc,1,2; Anass Benali, MSc,1,2; Ann-Christin Rathert, MSc,1,2; Ruben Martín-Pinardel, MSc,1,2,3; Carolina Bernal-Morales, MD, PhD,4; Anibal Alé-Chilet, MD,4; Marina Barraso, MD, PhD,4; Sara Marín-Martinez, MD,4; Silvia Feu-Basilio, MD,4; Josep Rosinés-Fonoll, MD, 4; Teresa Hernandez, OD,3,4; Irene Vilá, OD,3,4; Rafael Castro-Dominguez, OD,4; Cristian Oliva, OD,3,4; Irene Vinagre, MD, PhD,3,5,6; Emilio Ortega, MD, PhD,3,5,6; Marga Gimenez, MD, PhD,3,5,6; Alfredo Vellido, PhD,1,2; Enrique Romero, PhD,1,2; Javier Zarranz-Ventura, MD, PhD3,4,5,7 // 1 Intelligent Data Science and Artificial Intelligence (IDEAI) Research Center; 2 Department of Computer Science, Facultat d’Informàtica de Barcelona (FIB), Universitat Politècnica de Catalunya (UPC), Barcelona, Spain; 3 August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; 4 Institut Clínic d'Oftalmología (ICOF), Hospital Clínic de Barcelona, Barcelona, Spain; 5 Diabetes Unit, Hospital Clínic de Barcelona, Spain; 6 Institut Clínic de Malalties Digestives i Metaboliques (ICMDM), Hospital Clínic de Barcelona, Spain; 7 School of Medicine, Universitat de Barcelona, Spain.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous

  • Ungan, Gülnur
  • Pons Escoda, Albert
  • Ulinic, Daniel
  • Arus Caraltó, Carles
  • Ortega Martorell, Sandra
  • Olier Caparroso, Iván
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
  • Majós, Carles
  • Julia Sape, Margarida
The standard treatment in glioblastoma includes maximal safe resection followed by concomitant radiotherapy plus chemotherapy and adjuvant temozolomide. The first follow-up study to evaluate treatment response is performed 1¿month after concomitant treatment, when contrast-enhancing regions may appear that can correspond to true progression or pseudoprogression. We retrospectively evaluated 31 consecutive patients at the first follow-up after concomitant treatment to check whether the metabolic pattern assessed with multivoxel MRS was predictive of treatment response 2¿months later. We extracted the underlying metabolic patterns of the contrast-enhancing regions with a blind-source separation method and mapped them over the reference images. Pattern heterogeneity was calculated using entropy, and association between patterns and outcomes was measured with Cramér's V. We identified three distinct metabolic patterns—proliferative, necrotic, and responsive, which were associated with status 2¿months later. Individually, 70% of the patients showed metabolically heterogeneous patterns in the contrast-enhancing regions. Metabolic heterogeneity was not related to the regions' size and only stable patients were less heterogeneous than the rest. Contrast-enhancing regions are also metabolically heterogeneous 1¿month after concomitant treatment. This could explain the reported difficulty in finding robust pseudoprogression biomarkers., "Funding information: H2020-EU.1.3. EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Instituto de Salud Carlos III (ISCIII), Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad, SAF2014-52332-R. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN, http://www.ciber-bbn.es/en, accessed December 29, 2023), CB06/01/0010, an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. Generalitat de Catalunya, Xartecsalut, 2018 XARDI 00016 and 2021 XARDI 00021.", Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Layer-wise relevance analysis for motif recognition in the activation pathway of the ß2-adrenergic GPCR receptor

  • Gutiérrez Mondragón, Mario Alberto
  • König, Caroline|||0000-0002-7543-8686
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
G-protein-coupled receptors (GPCRs) are cell membrane proteins of relevance as therapeutic targets, and are associated to the development of treatments for illnesses such as diabetes, Alzheimer’s, or even cancer. Therefore, comprehending the underlying mechanisms of the receptor functional properties is of particular interest in pharmacoproteomics and in disease therapy at large. Their interaction with ligands elicits multiple molecular rearrangements all along their structure, inducing activation pathways that distinctly influence the cell response. In this work, we studied GPCR signaling pathways from molecular dynamics simulations as they provide rich information about the dynamic nature of the receptors. We focused on studying the molecular properties of the receptors using deep-learning-based methods. In particular, we designed and trained a one-dimensional convolution neural network and illustrated its use in a classification of conformational states: active, intermediate, or inactive, of the ß2 -adrenergic receptor when bound to the full agonist BI-167107. Through a novel explainability-oriented investigation of the prediction results, we were able to identify and assess the contribution of individual motifs (residues) influencing a particular activation pathway. Consequently, we contribute a methodology that assists in the elucidation of the underlying mechanisms of receptor activation–deactivation., This research was funded by Spanish PID2019-104551RB-I00 research project., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

A comparison of non-negative matrix underapproximation methods for the decomposition of magnetic resonance spectroscopy data from human brain tumors

  • Ungan, Gülnur
  • Arus Caraltó, Carles
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
  • Julia Sape, Margarida
Magnetic resonance spectroscopy (MRS) is an MR technique that provides informa-tion about the biochemistry of tissues in a noninvasive way. MRS has been widelyused for the study of brain tumors, both preoperatively and during follow-up. In thisstudy, we investigated the performance of a range of variants of unsupervised matrixfactorization methods of the non-negative matrix underapproximation (NMU) family,namely, sparse NMU, global NMU, and recursive NMU, and compared them withconvex non-negative matrix factorization (C-NMF), which has previously shown agood performance on brain tumor diagnostic support problems using MRS data. Thepurpose of the investigation was 2-fold: first, to ascertain the differences among thesources extracted by these methods; and second, to compare the influence of eachmethod in the diagnostic accuracy of the classification of brain tumors, using them asfeature extractors. We discovered that, first, NMU variants found meaningful sourcesin terms of biological interpretability, but representing parts of the spectrum, incontrast to C-NMF; and second, that NMU methods achieved better classificationaccuracy than C-NMF for the classification tasks when one class was notmeningioma., H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad SAF2014-52332-R. AEI Research Project PID2019-104551RB-I00. Centro de Investigacion Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on September 12, 2022], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. XartecSalut, 2018 XARDI 00016 and 2021 XARDI 00021., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Advances in the use of deep learning for the analysis of magnetic resonance image in neuro-oncology

  • Pitarch i Abaigar, Carla|||0000-0002-6015-244X
  • Ungan, Gülnur
  • Julia Sape, Margarida
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
Machine Learning is entering a phase of maturity, but its medical applications still lag behind in terms of practical use. The field of oncological radiology (and neuro-oncology in particular) is at the forefront of these developments, now boosted by the success of Deep-Learning methods for the analysis of medical images. This paper reviews in detail some of the most recent advances in the use of Deep Learning in this field, from the broader topic of the development of Machine-Learning-based analytical pipelines to specific instantiations of the use of Deep Learning in neuro-oncology; the latter including its use in the groundbreaking field of ultra-low field magnetic resonance imaging., This research was funded by H2020-EU.1.3.—EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120; Proyectos de investigación en salud 2020, grant number PI20/00064. PID2019-104551RB-I00; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN (http://www.ciber-bbn.es/en, accessed on 3 November 2023), CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER); Spanish Agencia Española de Investigación (AEI) PID2022-143299OB-I00 grant; XartecSalut 2021-XARDI-00021. Carla Pitarch is a fellow of Eurecat’s “Vicente López” Ph.D. grant program., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Using single-voxel magnetic resonance spectroscopy data acquired at 1.5T to classify multivoxel data at 3T: a proof-of-concept study

  • Ungan, Gülnur
  • Pons Escoda, Albert
  • Ulinic, Daniel
  • Arus Caraltó, Carles
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
  • Julia Sape, Margarida
In vivo magnetic resonance spectroscopy (MRS) has two modalities, single-voxel (SV) and multivoxel (MV), in which one or more contiguous grids of SVs are acquired. Purpose: To test whether MV grids can be classified with models trained with SV. Methods: Retrospective study. Training dataset: Multicenter multiformat SV INTERPRET, 1.5T. Testing dataset: MV eTumour, 3T. Two classification tasks were completed: 3-class (meningioma vs. aggressive vs. normal) and 4-class (meningioma vs. low-grade glioma vs. aggressive vs. normal). Five different methods were tested for feature selection. The classification was implemented using linear discriminant analysis (LDA), random forest, and support vector machines. The evaluation was completed with balanced error rate (BER) and area under the curve (AUC) on both sets. The accuracy in class prediction was calculated by developing a solid tumor index (STI) and segmentation accuracy with the Dice score. Results: The best method was sequential forward feature selection combined with LDA, with AUCs = 0.95 (meningioma), 0.89 (aggressive), 0.82 (low-grade glioma), and 0.82 (normal). STI was 66% (4-class task) and 71% (3-class task) because two cases failed completely and two more had suboptimal STI as defined by us. Discussion: The reasons for failure in the classification of the MV test set were related to the presence of artifacts., H2020-EU.1.3.—EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad SAF2014-52332-R. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on 12 January 2023], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by the EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. Xartecsalut, 2018 XARDI 00,016 and 2021 XARDI 00021. eTUMOUR: FP6-2002-LIFESCIHEALTH- 503094. INTERPRET: FP5-IST-1999-10310., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

GPCR molecular dynamics forecasting using recurrent neural networks

  • López Correa, Juan Manuel
  • König, Caroline|||0000-0002-7543-8686
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
G protein-coupled receptors (GPCRs) are a large superfamily of cell membrane proteins that play an important physiological role as transmitters of extracellular signals. Signal transmission through the cell membrane depends on conformational changes in the transmembrane region of the receptor, which makes the investigation of the dynamics in these regions particularly relevant. Molecular dynamics (MD) simulations provide a wealth of data about the structure, dynamics, and physiological function of biological macromolecules by modelling the interactions between their atomic constituents. In this study, a Recurrent and Convolutional Neural Network (RNN) model, namely Long Short-Term Memory (LSTM), is used to predict the dynamics of two GPCR states and three specific simulations of each one, through their activation path and focussing on specific receptor regions. Active and inactive states of the GPCRs are analysed in six scenarios involving APO, Full Agonist (BI 167107) and Partial Inverse Agonist (carazolol) of the receptor. Four Machine Learning models with increasing complexity in terms of neural network architecture are evaluated, and their results discussed. The best method achieves an overall RMSD lower than 0.139 Å and the transmembrane helices are the regions showing the minimum prediction errors and minimum relative movements of the protein., This work is funded by Spanish PID2019-104551RB-I00 research project and by the PRE2020-092428 Ph.D. training program, through the Ministry of Science and Innovation., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

GPCR molecular dynamics forecasting using recurrent neural networks

  • López Correa, Juan Manuel
  • König, Caroline
  • Vellido Alcacena, Alfredo
G protein-coupled receptors (GPCRs) are a large superfamily of cell membrane proteins that play an important physiological role as transmitters of extracellular signals. Signal transmission through the cell membrane depends on conformational changes in the transmembrane region of the receptor, which makes the investigation of the dynamics in these regions particularly relevant. Molecular dynamics (MD) simulations provide a wealth of data about the structure, dynamics, and physiological function of biological macromolecules by modelling the interactions between their atomic constituents. In this study, a Recurrent and Convolutional Neural Network (RNN) model, namely Long Short-Term Memory (LSTM), is used to predict the dynamics of two GPCR states and three specific simulations of each one, through their activation path and focussing on specific receptor regions. Active and inactive states of the GPCRs are analysed in six scenarios involving APO, Full Agonist (BI 167107) and Partial Inverse Agonist (carazolol) of the receptor. Four Machine Learning models with increasing complexity in terms of neural network architecture are evaluated, and their results discussed. The best method achieves an overall RMSD lower than 0.139 Å and the transmembrane helices are the regions showing the minimum prediction errors and minimum relative movements of the protein., This work is funded by Spanish PID2019-104551RB-I00 research project and by the PRE2020-092428 Ph.D. training program, through the Ministry of Science and Innovation., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Using single-voxel magnetic resonance spectroscopy data acquired at 1.5T to classify multivoxel data at 3T: a proof-of-concept study

  • Ungan, Gülnur
  • Pons Escoda, Albert
  • Ulinic, Daniel
  • Arus Caraltó, Carles
  • Vellido Alcacena, Alfredo
  • Julia Sape, Margarida
In vivo magnetic resonance spectroscopy (MRS) has two modalities, single-voxel (SV) and multivoxel (MV), in which one or more contiguous grids of SVs are acquired. Purpose: To test whether MV grids can be classified with models trained with SV. Methods: Retrospective study. Training dataset: Multicenter multiformat SV INTERPRET, 1.5T. Testing dataset: MV eTumour, 3T. Two classification tasks were completed: 3-class (meningioma vs. aggressive vs. normal) and 4-class (meningioma vs. low-grade glioma vs. aggressive vs. normal). Five different methods were tested for feature selection. The classification was implemented using linear discriminant analysis (LDA), random forest, and support vector machines. The evaluation was completed with balanced error rate (BER) and area under the curve (AUC) on both sets. The accuracy in class prediction was calculated by developing a solid tumor index (STI) and segmentation accuracy with the Dice score. Results: The best method was sequential forward feature selection combined with LDA, with AUCs = 0.95 (meningioma), 0.89 (aggressive), 0.82 (low-grade glioma), and 0.82 (normal). STI was 66% (4-class task) and 71% (3-class task) because two cases failed completely and two more had suboptimal STI as defined by us. Discussion: The reasons for failure in the classification of the MV test set were related to the presence of artifacts., H2020-EU.1.3.—EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad SAF2014-52332-R. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on 12 January 2023], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by the EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. Xartecsalut, 2018 XARDI 00,016 and 2021 XARDI 00021. eTUMOUR: FP6-2002-LIFESCIHEALTH- 503094. INTERPRET: FP5-IST-1999-10310., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A comparison of non-negative matrix underapproximation methods for the decomposition of magnetic resonance spectroscopy data from human brain tumors

  • Ungan, Gülnur
  • Arus Caraltó, Carles
  • Vellido Alcacena, Alfredo
  • Julia Sape, Margarida
Magnetic resonance spectroscopy (MRS) is an MR technique that provides informa-tion about the biochemistry of tissues in a noninvasive way. MRS has been widelyused for the study of brain tumors, both preoperatively and during follow-up. In thisstudy, we investigated the performance of a range of variants of unsupervised matrixfactorization methods of the non-negative matrix underapproximation (NMU) family,namely, sparse NMU, global NMU, and recursive NMU, and compared them withconvex non-negative matrix factorization (C-NMF), which has previously shown agood performance on brain tumor diagnostic support problems using MRS data. Thepurpose of the investigation was 2-fold: first, to ascertain the differences among thesources extracted by these methods; and second, to compare the influence of eachmethod in the diagnostic accuracy of the classification of brain tumors, using them asfeature extractors. We discovered that, first, NMU variants found meaningful sourcesin terms of biological interpretability, but representing parts of the spectrum, incontrast to C-NMF; and second, that NMU methods achieved better classificationaccuracy than C-NMF for the classification tasks when one class was notmeningioma., H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad SAF2014-52332-R. AEI Research Project PID2019-104551RB-I00. Centro de Investigacion Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on September 12, 2022], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. XartecSalut, 2018 XARDI 00016 and 2021 XARDI 00021., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Advances in the use of deep learning for the analysis of magnetic resonance image in neuro-oncology

  • Pitarch i Abaigar, Carla
  • Ungan, Gülnur
  • Julia Sape, Margarida
  • Vellido Alcacena, Alfredo
Machine Learning is entering a phase of maturity, but its medical applications still lag behind in terms of practical use. The field of oncological radiology (and neuro-oncology in particular) is at the forefront of these developments, now boosted by the success of Deep-Learning methods for the analysis of medical images. This paper reviews in detail some of the most recent advances in the use of Deep Learning in this field, from the broader topic of the development of Machine-Learning-based analytical pipelines to specific instantiations of the use of Deep Learning in neuro-oncology; the latter including its use in the groundbreaking field of ultra-low field magnetic resonance imaging., This research was funded by H2020-EU.1.3.—EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120; Proyectos de investigación en salud 2020, grant number PI20/00064. PID2019-104551RB-I00; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN (http://www.ciber-bbn.es/en, accessed on 3 November 2023), CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER); Spanish Agencia Española de Investigación (AEI) PID2022-143299OB-I00 grant; XartecSalut 2021-XARDI-00021. Carla Pitarch is a fellow of Eurecat’s “Vicente López” Ph.D. grant program., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous

  • Ungan, Gülnur
  • Pons Escoda, Albert
  • Ulinic, Daniel
  • Arus Caraltó, Carles
  • Ortega Martorell, Sandra
  • Olier Caparroso, Iván
  • Vellido Alcacena, Alfredo
  • Majós, Carles
  • Julia Sape, Margarida
The standard treatment in glioblastoma includes maximal safe resection followed by concomitant radiotherapy plus chemotherapy and adjuvant temozolomide. The first follow-up study to evaluate treatment response is performed 1¿month after concomitant treatment, when contrast-enhancing regions may appear that can correspond to true progression or pseudoprogression. We retrospectively evaluated 31 consecutive patients at the first follow-up after concomitant treatment to check whether the metabolic pattern assessed with multivoxel MRS was predictive of treatment response 2¿months later. We extracted the underlying metabolic patterns of the contrast-enhancing regions with a blind-source separation method and mapped them over the reference images. Pattern heterogeneity was calculated using entropy, and association between patterns and outcomes was measured with Cramér's V. We identified three distinct metabolic patterns—proliferative, necrotic, and responsive, which were associated with status 2¿months later. Individually, 70% of the patients showed metabolically heterogeneous patterns in the contrast-enhancing regions. Metabolic heterogeneity was not related to the regions' size and only stable patients were less heterogeneous than the rest. Contrast-enhancing regions are also metabolically heterogeneous 1¿month after concomitant treatment. This could explain the reported difficulty in finding robust pseudoprogression biomarkers., "Funding information: H2020-EU.1.3. EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Instituto de Salud Carlos III (ISCIII), Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad, SAF2014-52332-R. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN, http://www.ciber-bbn.es/en, accessed December 29, 2023), CB06/01/0010, an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. Generalitat de Catalunya, Xartecsalut, 2018 XARDI 00016 and 2021 XARDI 00021.", Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Radiomics-based assessment of optical coherence tomography angiography images for diabetic retinopathy diagnosis

  • Carrera Escale, Laura
  • Benali Bendahmane, Anass
  • Rathert, Ann Christin
  • Martín Pinardel, Ruben
  • Bernal Morales, Carolina
  • Alé Chilet, Anibal
  • Barraso Rodrigo, Marina
  • Marín Martinez, Sara
  • Vellido Alcacena, Alfredo
  • Romero Merino, Enrique
Purpose: To evaluate the diagnostic accuracy of machine learning (ML) techniques applied to radiomic features extracted from OCT and OCT angiography (OCTA) images for diabetes mellitus (DM), diabetic retinopathy (DR), and referable DR (R-DR) diagnosis. Design: Cross-sectional analysis of a retinal image dataset from a previous prospective OCTA study (ClinicalTrials.gov NCT03422965). Participants: Patients with type 1 DM and controls included in the progenitor study. Methods: Radiomic features were extracted from fundus retinographies, OCT, and OCTA images in each study eye. Logistic regression, linear discriminant analysis, support vector classifier (SVC)-linear, SVC-radial basis function, and random forest models were created to evaluate their diagnostic accuracy for DM, DR, and R-DR diagnosis in all image types. Main Outcome Measures: Area under the receiver operating characteristic curve (AUC) mean and standard deviation for each ML model and each individual and combined image types. Results: A dataset of 726 eyes (439 individuals) were included. For DM diagnosis, the greatest AUC was observed for OCT (0.82, 0.03). For DR detection, the greatest AUC was observed for OCTA (0.77, 0.03), especially in the 3 x 3 mm superficial capillary plexus OCTA scan (0.76, 0.04). For R-DR diagnosis, the greatest AUC was observed for OCTA (0.87, 0.12) and the deep capillary plexus OCTA scan (0.86, 0.08). The addition of clinical variables (age, sex, etc.) improved most models AUC for DM, DR and R-DR diagnosis. The performance of the models was similar in unilateral and bilateral eyes image datasets. Conclusions: Radiomics extracted from OCT and OCTA images allow identification of patients with DM, DR, and R-DR using standard ML classifiers. OCT was the best test for DM diagnosis, OCTA for DR and R-DR diagnosis and the addition of clinical variables improved most models. This pioneer study demonstrates that radiomics-based ML techniques applied to OCT and OCTA images may be an option for DR screening in patients with type 1 DM., The authors made the following disclosures: A.V.: Grants e Spanish research grant (grant no.: PID2019-104551RB-I00). J.Z.V.: Grant e Fundació La Marató de TV3, La Marató 2015, Diabetis i Obesitat (grant no.: 201633.10), Instituto de Salud Carlos III (grant nos.: PI18/00518, PI21/01384). E.R.: Grant e Spanish research grant (grant no.: PID2019-104551RB-I00)., Peer Reviewed, Article signat per 20 autors/es: Laura Carrera-Escalé, MSc,1,2; Anass Benali, MSc,1,2; Ann-Christin Rathert, MSc,1,2; Ruben Martín-Pinardel, MSc,1,2,3; Carolina Bernal-Morales, MD, PhD,4; Anibal Alé-Chilet, MD,4; Marina Barraso, MD, PhD,4; Sara Marín-Martinez, MD,4; Silvia Feu-Basilio, MD,4; Josep Rosinés-Fonoll, MD, 4; Teresa Hernandez, OD,3,4; Irene Vilá, OD,3,4; Rafael Castro-Dominguez, OD,4; Cristian Oliva, OD,3,4; Irene Vinagre, MD, PhD,3,5,6; Emilio Ortega, MD, PhD,3,5,6; Marga Gimenez, MD, PhD,3,5,6; Alfredo Vellido, PhD,1,2; Enrique Romero, PhD,1,2; Javier Zarranz-Ventura, MD, PhD3,4,5,7 // 1 Intelligent Data Science and Artificial Intelligence (IDEAI) Research Center; 2 Department of Computer Science, Facultat d’Informàtica de Barcelona (FIB), Universitat Politècnica de Catalunya (UPC), Barcelona, Spain; 3 August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; 4 Institut Clínic d'Oftalmología (ICOF), Hospital Clínic de Barcelona, Barcelona, Spain; 5 Diabetes Unit, Hospital Clínic de Barcelona, Spain; 6 Institut Clínic de Malalties Digestives i Metaboliques (ICMDM), Hospital Clínic de Barcelona, Spain; 7 School of Medicine, Universitat de Barcelona, Spain., Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Machine learning for clinical decision-making: challenges and opportunities in cardiovascular imaging

  • Sanchez-Martinez, Sergio
  • Camara, Oscar
  • Piella Fenoy, Gemma
  • Cikes, Maja
  • González Ballester, Miguel Ángel, 1973-
  • Miron, Marius
  • Vellido Alcacena, Alfredo
  • Gómez, Emilia
  • Fraser, Alan G.
  • Bijnens, Bart
The use of machine learning (ML) approaches to target clinical problems is called to revolutionize clinical decision-making in cardiology. The success of these tools is dependent on the understanding of the intrinsic processes being used during the conventional pathway by which clinicians make decisions. In a parallelism with this pathway, ML can have an impact at four levels: for data acquisition, predominantly by extracting standardized, high-quality information with the smallest possible learning curve; for feature extraction, by discharging healthcare practitioners from performing tedious measurements on raw data; for interpretation, by digesting complex, heterogeneous data in order to augment the understanding of the patient status; and for decision support, by leveraging the previous steps to predict clinical outcomes, response to treatment or to recommend a specific intervention. This paper discusses the state-of-the-art, as well as the current clinical status and challenges associated with the two later tasks of interpretation and decision support, together with the challenges related to the learning process, the auditability/traceability, the system infrastructure and the integration within clinical processes in cardiovascular imaging., This study was supported by the Spanish Ministry of Economy and Competitiveness (María de Maeztu Programme for R&D [MDM-2015-0502], Madrid, Spain) and by the Fundació La Marató de TV3 (n°20154031, Barcelona, Spain). The work of SS-M was supported by IDIBAPS and by the HUMAINT project of the Joint Research Centre of the European Commission. AV's contribution is funded by Spanish research project PID2019-104551RB-I00.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Layer-wise relevance analysis for motif recognition in the activation pathway of the ß2-adrenergic GPCR receptor

  • Gutiérrez Mondragón, Mario Alberto
  • König, Caroline
  • Vellido Alcacena, Alfredo
G-protein-coupled receptors (GPCRs) are cell membrane proteins of relevance as therapeutic targets, and are associated to the development of treatments for illnesses such as diabetes, Alzheimer’s, or even cancer. Therefore, comprehending the underlying mechanisms of the receptor functional properties is of particular interest in pharmacoproteomics and in disease therapy at large. Their interaction with ligands elicits multiple molecular rearrangements all along their structure, inducing activation pathways that distinctly influence the cell response. In this work, we studied GPCR signaling pathways from molecular dynamics simulations as they provide rich information about the dynamic nature of the receptors. We focused on studying the molecular properties of the receptors using deep-learning-based methods. In particular, we designed and trained a one-dimensional convolution neural network and illustrated its use in a classification of conformational states: active, intermediate, or inactive, of the ß2 -adrenergic receptor when bound to the full agonist BI-167107. Through a novel explainability-oriented investigation of the prediction results, we were able to identify and assess the contribution of individual motifs (residues) influencing a particular activation pathway. Consequently, we contribute a methodology that assists in the elucidation of the underlying mechanisms of receptor activation–deactivation., This research was funded by Spanish PID2019-104551RB-I00 research project., Peer Reviewed, Postprint (published version)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Using Single-Voxel Magnetic Resonance Spectroscopy Data Acquired at 1.5T to Classify Multivoxel Data at 3T, A Proof-of-Concept Study

  • Ungan, Gulnur Semahat|||0000-0002-5436-4665
  • Pons-Escoda, Albert|||0000-0003-4167-8291
  • Ulinic, Daniel|||0009-0006-3318-0839
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Vellido, Alfredo|||0000-0002-9843-1911
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
In vivo magnetic resonance spectroscopy (MRS) has two modalities, single-voxel (SV) and multivoxel (MV), in which one or more contiguous grids of SVs are acquired. Purpose: To test whether MV grids can be classified with models trained with SV. Methods: Retrospective study. Training dataset: Multicenter multiformat SV INTERPRET, 1.5T. Testing dataset: MV eTumour, 3T. Two classification tasks were completed: 3-class (meningioma vs. aggressive vs. normal) and 4-class (meningioma vs. low-grade glioma vs. aggressive vs. normal). Five different methods were tested for feature selection. The classification was implemented using linear discriminant analysis (LDA), random forest, and support vector machines. The evaluation was completed with balanced error rate (BER) and area under the curve (AUC) on both sets. The accuracy in class prediction was calculated by developing a solid tumor index (STI) and segmentation accuracy with the Dice score. Results: The best method was sequential forward feature selection combined with LDA, with AUCs = 0.95 (meningioma), 0.89 (aggressive), 0.82 (low-grade glioma), and 0.82 (normal). STI was 66% (4-class task) and 71% (3-class task) because two cases failed completely and two more had suboptimal STI as defined by us. Discussion: The reasons for failure in the classification of the MV test set were related to the presence of artifacts.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A comparison of non-negative matrix underapproximation methods for the decomposition of magnetic resonance spectroscopy data from human brain tumors

  • Ungan, Gulnur Semahat|||0000-0002-5436-4665
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Vellido, Alfredo|||0000-0002-9843-1911
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
Magnetic resonance spectroscopy (MRS) is an MR technique that provides information about the biochemistry of tissues in a noninvasive way. MRS has been widely used for the study of brain tumors, both preoperatively and during follow-up. In this study, we investigated the performance of a range of variants of unsupervised matrix factorization methods of the non-negative matrix underapproximation (NMU) family, namely, sparse NMU, global NMU, and recursive NMU, and compared them with convex non-negative matrix factorization (C-NMF), which has previously shown a good performance on brain tumor diagnostic support problems using MRS data. The purpose of the investigation was 2-fold: first, to ascertain the differences among the sources extracted by these methods; and second, to compare the influence of each method in the diagnostic accuracy of the classification of brain tumors, using them as feature extractors. We discovered that, first, NMU variants found meaningful sources in terms of biological interpretability, but representing parts of the spectrum, in contrast to C-NMF; and second, that NMU methods achieved better classification accuracy than C-NMF for the classification tasks when one class was not meningioma.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous

  • Ungan, Gulnur Semahat|||0000-0002-5436-4665
  • Pons-Escoda, Albert|||0000-0003-4167-8291
  • Ulinic, Daniel|||0009-0006-3318-0839
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Ortega-Martorell, Sandra|||0000-0001-9927-3209
  • Olier, Iván|||0000-0002-5679-7501
  • Vellido, Alfredo|||0000-0002-9843-1911
  • Majos, Carles|||0000-0003-0468-5150
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
The standard treatment in glioblastoma includes maximal safe resection followed by concomitant radiotherapy plus chemotherapy and adjuvant temozolomide. The first follow-up study to evaluate treatment response is performed 1 month after concomitant treatment, when contrast-enhancing regions may appear that can correspond to true progression or pseudoprogression. We retrospectively evaluated 31 consecutive patients at the first follow-up after concomitant treatment to check whether the metabolic pattern assessed with multivoxel MRS was predictive of treatment response 2 months later. We extracted the underlying metabolic patterns of the contrast-enhancing regions with a blind-source separation method and mapped them over the reference images. Pattern heterogeneity was calculated using entropy, and association between patterns and outcomes was measured with Cramér's V. We identified three distinct metabolic patterns-proliferative, necrotic, and responsive, which were associated with status 2 months later. Individually, 70% of the patients showed metabolically heterogeneous patterns in the contrast-enhancing regions. Metabolic heterogeneity was not related to the regions' size and only stable patients were less heterogeneous than the rest. Contrast-enhancing regions are also metabolically heterogeneous 1 month after concomitant treatment. This could explain the reported difficulty in finding robust pseudoprogression biomarkers.